[Treatment with infliximab in patients with Crohn disease; experience in 132 patients].
Smits
S R J G
SR
Heijman
J A
JA
van Dullemen
H M
HM
Rutten
W J M J
WJ
Annemans
L
L
Brouwers
J R B J
JR
Postma
M J
MJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D009426:Netherlands; D011306:Prescription Fees
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab